Myoblast Cell Grafting into Heart Muscle: Cellular Biology and Potential Applications
Overview
Authors
Affiliations
This review surveys a wide range of cellular and molecular approaches to strengthening the injured or weakened heart, focusing on strategies to replace dysfunctional, necrotic, or apoptotic cardiomyocytes with new cells of mesodermal origin. A variety of cell types, including myogenic cell lines, adult skeletal myoblasts, immoratalized atrial cells, embryonic and adult cardiomyocytes, embryonic stem cells, tetratoma cells, genetically altered fibroblasts, smooth muscle cells, and bone marrow-derived cells have all been proposed as useful cells in cardiac repair and may have the capacity to perform cardiac work. We focus on the implantation of mesodermally derived cells, the best developed of the options. We review the developmental and cell biology that have stimulated these studies, examine the limitations of current knowledge, and identify challenges for the future, which we believe are considerable.
Sajjad M, Muzamil F, Sabir M, Ashfaq U Curr Stem Cell Res Ther. 2024; 20(1):50-71.
PMID: 38343052 DOI: 10.2174/011574888X263530230921074827.
Cell augmentation strategies for cardiac stem cell therapies.
Cruz-Samperio R, Jordan M, Perriman A Stem Cells Transl Med. 2021; 10(6):855-866.
PMID: 33660953 PMC: 8133336. DOI: 10.1002/sctm.20-0489.
Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair.
Hassan N, Tchao J, Tobita K Stem Cells Transl Med. 2013; 3(2):183-93.
PMID: 24371329 PMC: 3925055. DOI: 10.5966/sctm.2013-0122.
Lang C, Lehner S, Todica A, Boening G, Franz W, Bartenstein P Eur J Nucl Med Mol Imaging. 2013; 40(11):1730-8.
PMID: 23860738 DOI: 10.1007/s00259-013-2480-1.
Sekiya N, Tobita K, Beckman S, Okada M, Gharaibeh B, Sawa Y Mol Ther. 2013; 21(3):662-9.
PMID: 23319053 PMC: 3589171. DOI: 10.1038/mt.2012.266.